SIMILAR PATTERNS OF AMINO ACIDS FOR 4QRC_A_0LIA802

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism		 Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1coy CHOLESTEROL OXIDASE

(Brevibacterium
sterolicum) 		PF00732
(GMC_oxred_N)
PF05199
(GMC_oxred_C) 		5 ALA A  27
LEU A 298
ALA A 288
ASP A 474
LEU A 477
 None
None
None
FAD  A 510 (-4.7A)
None
 1.11A 4qrcA-1coyA:
undetectable		 4qrcA-1coyA:
18.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jr1 INOSINE-5'-MONOPHOSP
HATE DEHYDROGENASE 2

(Cricetulus
griseus) 		PF00478
(IMPDH)
PF00571
(CBS) 		5 ALA A 248
MET A 290
VAL A 271
ALA A 264
ASP A 261
 None
 1.07A 4qrcA-1jr1A:
undetectable		 4qrcA-1jr1A:
21.90
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1k9a CARBOXYL-TERMINAL
SRC KINASE

(Rattus
norvegicus) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		5 ALA A 220
GLU A 236
MET A 240
LEU A 305
ARG A 313
 None
 0.72A 4qrcA-1k9aA:
31.3		 4qrcA-1k9aA:
30.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1o8c YHDH

(Escherichia
coli) 		PF00107
(ADH_zinc_N)
PF08240
(ADH_N) 		5 ALA A 176
VAL A 152
LEU A 282
ALA A 165
LEU A 170
 None
 1.13A 4qrcA-1o8cA:
undetectable		 4qrcA-1o8cA:
23.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1opk PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1

(Mus musculus) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		6 ALA A 288
GLU A 305
MET A 309
LEU A 373
ARG A 381
ALA A 399
 P16  A   2 (-3.4A)
P16  A   2 (-4.2A)
P16  A   2 (-3.3A)
None
None
P16  A   2 (-3.5A)
 0.83A 4qrcA-1opkA:
30.7		 4qrcA-1opkA:
29.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1py5 TGF-BETA RECEPTOR
TYPE I

(Homo sapiens) 		PF00069
(Pkinase)
PF08515
(TGF_beta_GS) 		5 ALA A 230
GLU A 245
LEU A 316
ARG A 332
ALA A 350
 PY1  A 700 (-3.5A)
PY1  A 700 ( 4.9A)
None
None
PY1  A 700 ( 4.2A)
 0.59A 4qrcA-1py5A:
26.1		 4qrcA-1py5A:
27.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tqy ACTINORHODIN
POLYKETIDE PUTATIVE
BETA-KETOACYL
SYNTHASE 1
ACTINORHODIN
POLYKETIDE PUTATIVE
BETA-KETOACYL
SYNTHASE 2

(Streptomyces
coelicolor) 		PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C) 		5 ALA B  75
GLU B 229
VAL B 187
LEU A 143
LEU B 191
 None
 1.15A 4qrcA-1tqyB:
undetectable		 4qrcA-1tqyB:
24.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ujn DEHYDROQUINATE
SYNTHASE

(Thermus
thermophilus) 		PF01761
(DHQ_synthase) 		6 ALA A 208
VAL A 209
LEU A 255
ARG A 276
ALA A 174
LEU A 187
 None
 1.27A 4qrcA-1ujnA:
undetectable		 4qrcA-1ujnA:
24.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v71 HYPOTHETICAL PROTEIN
C320.14 IN
CHROMOSOME III

(Schizosaccharomyces
pombe) 		PF00291
(PALP) 		5 ALA A  16
GLU A 170
VAL A  13
LEU A 178
ALA A 164
 None
 1.15A 4qrcA-1v71A:
undetectable		 4qrcA-1v71A:
20.96
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2dq7 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE FYN

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA X  37
GLU X  54
MET X  58
ARG X 129
ALA X 147
 STU  X 902 (-3.1A)
STU  X 902 ( 4.4A)
None
PTR  X 160 ( 3.4A)
STU  X 902 ( 4.1A)
 0.70A 4qrcA-2dq7X:
31.7		 4qrcA-2dq7X:
34.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hk5 TYROSINE-PROTEIN
KINASE HCK

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 ALA A 271
GLU A 288
MET A 292
ARG A 363
ALA A 381
ASP A 382
 1BM  A 499 (-3.6A)
1BM  A 499 (-3.2A)
1BM  A 499 ( 3.8A)
None
1BM  A 499 ( 3.7A)
1BM  A 499 (-4.4A)
 1.37A 4qrcA-2hk5A:
31.2		 4qrcA-2hk5A:
39.94
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hz0 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 ALA A 269
GLU A 286
MET A 290
ARG A 362
ALA A 380
ASP A 381
 GIN  A 600 (-3.1A)
GIN  A 600 (-3.6A)
GIN  A 600 (-3.2A)
None
GIN  A 600 (-3.1A)
GIN  A 600 (-4.9A)
 1.09A 4qrcA-2hz0A:
31.7		 4qrcA-2hz0A:
40.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hz0 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 ALA A 269
GLU A 286
MET A 290
LEU A 354
ARG A 362
ALA A 380
 GIN  A 600 (-3.1A)
GIN  A 600 (-3.6A)
GIN  A 600 (-3.2A)
GIN  A 600 ( 4.6A)
None
GIN  A 600 (-3.1A)
 0.82A 4qrcA-2hz0A:
31.7		 4qrcA-2hz0A:
40.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2og8 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE LCK

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 271
ARG A 363
ALA A 381
ASP A 382
PHE A 383
 1N8  A 501 ( 3.4A)
None
1N8  A 501 ( 3.3A)
1N8  A 501 ( 3.3A)
1N8  A 501 ( 4.3A)
 1.16A 4qrcA-2og8A:
31.4		 4qrcA-2og8A:
39.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2og8 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE LCK

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 ALA A 271
GLU A 288
MET A 292
ALA A 381
ASP A 382
PHE A 383
 1N8  A 501 ( 3.4A)
1N8  A 501 ( 3.6A)
1N8  A 501 ( 3.6A)
1N8  A 501 ( 3.3A)
1N8  A 501 ( 3.3A)
1N8  A 501 ( 4.3A)
 0.94A 4qrcA-2og8A:
31.4		 4qrcA-2og8A:
39.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ogv MACROPHAGE
COLONY-STIMULATING
FACTOR 1 RECEPTOR
PRECURSOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 ALA A 614
GLU A 633
MET A 637
LEU A 769
CYH A 774
ARG A 777
 None
 0.69A 4qrcA-2ogvA:
33.3		 4qrcA-2ogvA:
45.26
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2p4i ANGIOPOIETIN-1
RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 853
ARG A 963
ALA A 981
ASP A 982
PHE A 983
 MR9  A 301 (-3.5A)
None
MR9  A 301 (-3.2A)
MR9  A 301 (-4.2A)
MR9  A 301 (-4.4A)
 1.11A 4qrcA-2p4iA:
27.9		 4qrcA-2p4iA:
43.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2p4i ANGIOPOIETIN-1
RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 853
LEU A 955
ARG A 963
ALA A 981
PHE A 983
 MR9  A 301 (-3.5A)
MR9  A 301 (-4.4A)
None
MR9  A 301 (-3.2A)
MR9  A 301 (-4.4A)
 0.68A 4qrcA-2p4iA:
27.9		 4qrcA-2p4iA:
43.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2psq FIBROBLAST GROWTH
FACTOR RECEPTOR 2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		8 ALA A 515
GLU A 534
MET A 538
VAL A 564
LEU A 617
CYH A 622
ARG A 625
ALA A 643
 None
None
None
None
None
None
SO4  A 303 ( 2.9A)
None
 0.70A 4qrcA-2psqA:
36.4		 4qrcA-2psqA:
66.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2r2p EPHRIN TYPE-A
RECEPTOR 5

(Homo sapiens) 		PF07714
(Pkinase_Tyr)
PF14575
(EphA2_TM) 		5 ALA A 705
GLU A 724
MET A 728
LEU A 791
ARG A 799
 None
None
None
None
SO4  A   1 ( 3.1A)
 1.08A 4qrcA-2r2pA:
32.2		 4qrcA-2r2pA:
32.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2xik SERINE/THREONINE
PROTEIN KINASE 25

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  47
GLU A  66
LEU A 131
ARG A 139
ALA A 157
 J60  A1294 (-3.3A)
None
None
TPO  A 174 ( 2.9A)
J60  A1294 ( 4.2A)
 0.85A 4qrcA-2xikA:
18.7		 4qrcA-2xikA:
26.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2z8c INSULIN RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A1028
GLU A1047
MET A1051
LEU A1123
ARG A1131
 S91  A   1 (-3.2A)
None
None
None
PTR  A1163 ( 3.6A)
 0.99A 4qrcA-2z8cA:
31.4		 4qrcA-2z8cA:
37.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ayf NITRIC OXIDE
REDUCTASE

(Geobacillus
stearothermophilus) 		PF00115
(COX1) 		5 ALA A 375
VAL A 456
ALA A 477
PHE A 518
LEU A 472
 None
 0.94A 4qrcA-3ayfA:
undetectable		 4qrcA-3ayfA:
18.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3b2t FIBROBLAST GROWTH
FACTOR RECEPTOR 2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		7 ALA A 515
GLU A 534
MET A 538
VAL A 564
LEU A 617
CYH A 622
ARG A 625
 M33  A1996 (-3.3A)
None
None
None
None
None
None
 0.96A 4qrcA-3b2tA:
27.8		 4qrcA-3b2tA:
74.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3b2t FIBROBLAST GROWTH
FACTOR RECEPTOR 2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		7 ALA A 515
MET A 538
VAL A 564
LEU A 617
CYH A 622
ARG A 625
ALA A 643
 M33  A1996 (-3.3A)
None
None
None
None
None
None
 0.80A 4qrcA-3b2tA:
27.8		 4qrcA-3b2tA:
74.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3c1x HEPATOCYTE GROWTH
FACTOR RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 GLU A1127
MET A1131
LEU A1195
ALA A1221
ASP A1222
 CKK  A1500 (-3.4A)
CKK  A1500 (-3.4A)
CKK  A1500 (-4.4A)
CKK  A1500 (-3.4A)
CKK  A1500 (-4.5A)
 1.16A 4qrcA-3c1xA:
24.4		 4qrcA-3c1xA:
32.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3c4f BASIC FIBROBLAST
GROWTH FACTOR
RECEPTOR 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		7 ALA A 512
GLU A 531
MET A 535
VAL A 561
LEU A 614
ARG A 622
ALA A 640
 C4F  A   1 (-3.3A)
None
C4F  A   1 ( 3.7A)
C4F  A   1 ( 4.8A)
None
None
C4F  A   1 (-3.6A)
 0.92A 4qrcA-3c4fA:
40.3		 4qrcA-3c4fA:
70.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3c4f BASIC FIBROBLAST
GROWTH FACTOR
RECEPTOR 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		7 ALA A 512
GLU A 531
MET A 535
VAL A 561
LEU A 614
CYH A 619
ALA A 640
 C4F  A   1 (-3.3A)
None
C4F  A   1 ( 3.7A)
C4F  A   1 ( 4.8A)
None
None
C4F  A   1 (-3.6A)
 0.46A 4qrcA-3c4fA:
40.3		 4qrcA-3c4fA:
70.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3c4f BASIC FIBROBLAST
GROWTH FACTOR
RECEPTOR 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		7 GLU A 531
MET A 535
VAL A 561
LEU A 614
ARG A 622
ALA A 640
PHE A 489
 None
C4F  A   1 ( 3.7A)
C4F  A   1 ( 4.8A)
None
None
C4F  A   1 (-3.6A)
C4F  A   1 (-3.7A)
 1.18A 4qrcA-3c4fA:
40.3		 4qrcA-3c4fA:
70.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3d7u TYROSINE-PROTEIN
KINASE CSK

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 220
GLU A 236
MET A 240
LEU A 305
ARG A 313
 None
 0.72A 4qrcA-3d7uA:
25.5		 4qrcA-3d7uA:
40.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3dko EPHRIN TYPE-A
RECEPTOR 7

(Homo sapiens) 		PF07714
(Pkinase_Tyr)
PF14575
(EphA2_TM) 		5 ALA A 663
GLU A 682
MET A 686
LEU A 749
PHE A 777
 IHZ  A1001 (-3.3A)
IHZ  A1001 (-3.8A)
IHZ  A1001 (-3.5A)
None
IHZ  A1001 (-4.7A)
 0.80A 4qrcA-3dkoA:
31.7		 4qrcA-3dkoA:
32.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3h7v O-SUCCINYLBENZOATE
SYNTHASE

(Thermosynechococcus
elongatus) 		PF13378
(MR_MLE_C) 		5 ALA A 271
GLU A  54
CYH A  63
PHE A  87
LEU A  82
 None
 1.15A 4qrcA-3h7vA:
undetectable		 4qrcA-3h7vA:
21.35
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3hng VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 859
GLU A 878
VAL A 909
ARG A1021
ASP A1040
 8ST  A2001 ( 3.8A)
8ST  A2001 (-3.7A)
8ST  A2001 (-4.1A)
None
None
 1.04A 4qrcA-3hngA:
35.1		 4qrcA-3hngA:
45.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3hng VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 859
GLU A 878
VAL A 909
ARG A1021
PHE A1041
 8ST  A2001 ( 3.8A)
8ST  A2001 (-3.7A)
8ST  A2001 (-4.1A)
None
8ST  A2001 ( 3.7A)
 1.01A 4qrcA-3hngA:
35.1		 4qrcA-3hngA:
45.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3hng VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 ALA A 859
GLU A 878
VAL A 909
LEU A1013
CYH A1018
ARG A1021
 8ST  A2001 ( 3.8A)
8ST  A2001 (-3.7A)
8ST  A2001 (-4.1A)
8ST  A2001 (-4.6A)
8ST  A2001 ( 4.7A)
None
 0.73A 4qrcA-3hngA:
35.1		 4qrcA-3hngA:
45.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3hu5 ISOCHORISMATASE
FAMILY PROTEIN

(Desulfovibrio
vulgaris) 		PF00857
(Isochorismatase) 		5 ALA A  12
VAL A 131
ALA A 147
ASP A 146
PHE A 112
 None
 1.02A 4qrcA-3hu5A:
undetectable		 4qrcA-3hu5A:
21.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3k11 PUTATIVE GLYCOSYL
HYDROLASE

(Bacteroides
thetaiotaomicron) 		PF07470
(Glyco_hydro_88) 		5 ALA A 382
VAL A 381
LEU A 293
ALA A 426
LEU A 356
 None
 1.18A 4qrcA-3k11A:
undetectable		 4qrcA-3k11A:
21.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3kul EPHRIN TYPE-A
RECEPTOR 8

(Homo sapiens) 		PF07714
(Pkinase_Tyr)
PF14575
(EphA2_TM) 		5 ALA A 665
GLU A 684
MET A 688
LEU A 751
ARG A 759
 None
 0.96A 4qrcA-3kulA:
32.7		 4qrcA-3kulA:
34.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mdy BONE MORPHOGENETIC
PROTEIN RECEPTOR
TYPE-1B

(Homo sapiens) 		PF07714
(Pkinase_Tyr)
PF08515
(TGF_beta_GS) 		5 ALA A 229
GLU A 244
LEU A 315
ARG A 331
ALA A 349
 LDN  A   1 (-3.6A)
None
None
None
LDN  A   1 ( 3.8A)
 0.90A 4qrcA-3mdyA:
25.9		 4qrcA-3mdyA:
29.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3n54 SPORE GERMINATION
PROTEIN B3

(Bacillus
subtilis) 		PF05504
(Spore_GerAC) 		5 ALA B 201
VAL B 140
LEU B 216
ALA B 193
LEU B 130
 None
 1.13A 4qrcA-3n54B:
undetectable		 4qrcA-3n54B:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nng UNCHARACTERIZED
PROTEIN

(Bacteroides
fragilis) 		PF00754
(F5_F8_type_C) 		5 ALA A 216
VAL A 201
CYH A 203
LEU A 251
PHE A 328
 None
 1.10A 4qrcA-3nngA:
undetectable		 4qrcA-3nngA:
18.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nuu PKB-LIKE

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A 109
GLU A 130
MET A 134
ARG A 204
ASP A 223
 JOZ  A 361 (-3.4A)
SO4  A   5 (-3.1A)
None
SEP  A 241 ( 3.4A)
SO4  A   5 ( 4.5A)
 1.13A 4qrcA-3nuuA:
24.1		 4qrcA-3nuuA:
24.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nuu PKB-LIKE

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A 109
GLU A 130
MET A 134
LEU A 196
ARG A 204
 JOZ  A 361 (-3.4A)
SO4  A   5 (-3.1A)
None
None
SEP  A 241 ( 3.4A)
 0.80A 4qrcA-3nuuA:
24.1		 4qrcA-3nuuA:
24.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3nx4 PUTATIVE
OXIDOREDUCTASE

(Salmonella
enterica) 		PF00107
(ADH_zinc_N)
PF08240
(ADH_N) 		5 ALA A 176
VAL A 152
LEU A 282
ALA A 165
LEU A 170
 None
 1.12A 4qrcA-3nx4A:
undetectable		 4qrcA-3nx4A:
24.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3pfq PROTEIN KINASE C
BETA TYPE

(Rattus
norvegicus) 		PF00069
(Pkinase)
PF00130
(C1_1)
PF00168
(C2)
PF00433
(Pkinase_C) 		5 ALA A 369
GLU A 390
LEU A 457
ARG A 465
ALA A 483
 ANP  A 800 (-3.6A)
None
None
TPO  A 500 ( 2.9A)
ANP  A 800 ( 3.8A)
 1.14A 4qrcA-3pfqA:
16.5		 4qrcA-3pfqA:
19.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ppz SERINE/THREONINE-PRO
TEIN KINASE CTR1

(Arabidopsis
thaliana) 		PF07714
(Pkinase_Tyr) 		5 ALA A 576
GLU A 596
MET A 600
LEU A 665
ARG A 675
 STU  A   1 (-3.3A)
None
None
None
SEP  A 710 ( 3.6A)
 1.02A 4qrcA-3ppzA:
29.1		 4qrcA-3ppzA:
33.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3q4t ACTIVIN RECEPTOR
TYPE-2A

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A 217
GLU A 232
LEU A 303
ARG A 321
ALA A 339
 TAK  A   2 (-3.5A)
TAK  A   2 ( 4.9A)
None
None
TAK  A   2 ( 4.2A)
 1.12A 4qrcA-3q4tA:
24.7		 4qrcA-3q4tA:
28.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3s95 LIM DOMAIN KINASE 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 GLU A 384
MET A 388
LEU A 451
ARG A 459
ALA A 477
 STU  A   1 (-3.7A)
None
None
None
STU  A   1 ( 4.1A)
 1.02A 4qrcA-3s95A:
26.1		 4qrcA-3s95A:
29.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3she MAP KINASE-ACTIVATED
PROTEIN KINASE 3

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  71
GLU A  84
CYH A 120
LEU A 157
ARG A 165
 I85  A 350 (-3.3A)
None
I85  A 350 ( 3.8A)
None
None
 0.95A 4qrcA-3sheA:
12.9		 4qrcA-3sheA:
25.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3tt0 BASIC FIBROBLAST
GROWTH FACTOR
RECEPTOR 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		8 ALA A 512
GLU A 531
MET A 535
VAL A 561
LEU A 614
CYH A 619
ARG A 622
ALA A 640
 07J  A   1 (-3.5A)
07J  A   1 (-3.8A)
07J  A   1 (-3.8A)
07J  A   1 (-4.7A)
None
None
None
07J  A   1 (-3.2A)
 0.63A 4qrcA-3tt0A:
39.4		 4qrcA-3tt0A:
67.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3tt0 BASIC FIBROBLAST
GROWTH FACTOR
RECEPTOR 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 GLU A 531
MET A 535
VAL A 561
ARG A 622
ALA A 640
ASP A 641
 07J  A   1 (-3.8A)
07J  A   1 (-3.8A)
07J  A   1 (-4.7A)
None
07J  A   1 (-3.2A)
07J  A   1 (-4.7A)
 1.36A 4qrcA-3tt0A:
39.4		 4qrcA-3tt0A:
67.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3txo PROTEIN KINASE C ETA
TYPE

(Homo sapiens) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		5 ALA A 382
GLU A 403
LEU A 470
ARG A 478
ALA A 496
 07U  A   1 (-3.3A)
07U  A   1 ( 4.8A)
None
None
07U  A   1 ( 4.0A)
 1.05A 4qrcA-3txoA:
14.0		 4qrcA-3txoA:
24.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3vid VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 866
GLU A 885
VAL A 916
CYH A1024
ARG A1027
 4TT  A2001 (-3.5A)
None
None
None
None
 1.16A 4qrcA-3vidA:
35.1		 4qrcA-3vidA:
46.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3vid VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 866
GLU A 885
VAL A 916
LEU A1019
ASP A1046
 4TT  A2001 (-3.5A)
None
None
None
None
 0.88A 4qrcA-3vidA:
35.1		 4qrcA-3vidA:
46.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3vid VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 866
GLU A 885
VAL A 916
LEU A1019
CYH A1024
 4TT  A2001 (-3.5A)
None
None
None
None
 0.76A 4qrcA-3vidA:
35.1		 4qrcA-3vidA:
46.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3wzd VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 866
GLU A 885
VAL A 916
LEU A1019
CYH A1024
 LEV  A1201 (-3.5A)
LEV  A1201 (-3.7A)
LEV  A1201 ( 4.6A)
None
DTT  A1202 (-2.0A)
 0.49A 4qrcA-3wzdA:
28.9		 4qrcA-3wzdA:
50.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4a5o BIFUNCTIONAL PROTEIN
FOLD

(Pseudomonas
aeruginosa) 		PF00763
(THF_DHG_CYH)
PF02882
(THF_DHG_CYH_C) 		5 ALA A  52
VAL A  51
LEU A  86
ALA A  67
LEU A  70
 None
 1.02A 4qrcA-4a5oA:
undetectable		 4qrcA-4a5oA:
23.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4agd VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 866
GLU A 885
VAL A 916
ARG A1027
LEU A 802
 B49  A2000 (-3.5A)
None
B49  A2000 (-4.8A)
None
None
 1.02A 4qrcA-4agdA:
35.2		 4qrcA-4agdA:
49.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4agd VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 866
GLU A 885
VAL A 916
LEU A1019
ARG A1027
 B49  A2000 (-3.5A)
None
B49  A2000 (-4.8A)
None
None
 0.91A 4qrcA-4agdA:
35.2		 4qrcA-4agdA:
49.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4agd VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 866
GLU A 885
VAL A 916
LEU A1019
CYH A1024
 B49  A2000 (-3.5A)
None
B49  A2000 (-4.8A)
None
None
 0.87A 4qrcA-4agdA:
35.2		 4qrcA-4agdA:
49.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ckr EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		7 ALA A 653
GLU A 672
MET A 676
LEU A 757
ALA A 783
ASP A 784
PHE A 785
 DI1  A1000 (-3.6A)
DI1  A1000 (-3.8A)
DI1  A1000 (-3.6A)
DI1  A1000 (-4.4A)
DI1  A1000 (-3.7A)
DI1  A1000 (-4.1A)
DI1  A1000 (-4.5A)
 1.11A 4qrcA-4ckrA:
31.1		 4qrcA-4ckrA:
35.55
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ckr EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		7 GLU A 672
MET A 676
LEU A 757
ARG A 765
ALA A 783
ASP A 784
PHE A 785
 DI1  A1000 (-3.8A)
DI1  A1000 (-3.6A)
DI1  A1000 (-4.4A)
None
DI1  A1000 (-3.7A)
DI1  A1000 (-4.1A)
DI1  A1000 (-4.5A)
 1.21A 4qrcA-4ckrA:
31.1		 4qrcA-4ckrA:
35.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4crs SERINE/THREONINE-PRO
TEIN KINASE N2

(Homo sapiens) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		5 ALA A 684
GLU A 705
LEU A 773
ARG A 781
ALA A 799
 AGS  A1985 (-3.5A)
None
None
TPO  A 816 ( 3.0A)
AGS  A1985 ( 4.5A)
 0.86A 4qrcA-4crsA:
16.0		 4qrcA-4crsA:
27.37
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4e93 TYROSINE-PROTEIN
KINASE FES/FPS

(Homo sapiens) 		PF00017
(SH2)
PF07714
(Pkinase_Tyr) 		5 ALA A 588
GLU A 607
LEU A 674
CYH A 679
ARG A 682
 GUI  A 901 (-3.4A)
None
None
None
None
 1.08A 4qrcA-4e93A:
32.2		 4qrcA-4e93A:
33.83
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4f4p TYROSINE-PROTEIN
KINASE SYK

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 400
GLU A 420
MET A 424
LEU A 485
ARG A 493
 0SB  A 701 (-3.3A)
None
None
None
SO4  A 702 (-3.0A)
 0.97A 4qrcA-4f4pA:
29.3		 4qrcA-4f4pA:
37.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4fr4 SERINE/THREONINE-PRO
TEIN KINASE 32A

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  50
GLU A  71
VAL A 100
LEU A 137
ARG A 145
 STU  A 401 (-3.2A)
None
None
None
None
 0.60A 4qrcA-4fr4A:
21.4		 4qrcA-4fr4A:
21.66
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4hvi TYROSINE-PROTEIN
KINASE JAK3

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 ALA A 853
GLU A 871
LEU A 940
CYH A 945
ARG A 948
ALA A 966
 19S  A1201 (-3.3A)
None
None
None
None
19S  A1201 ( 4.1A)
 0.98A 4qrcA-4hviA:
30.6		 4qrcA-4hviA:
33.05
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4k33 FIBROBLAST GROWTH
FACTOR RECEPTOR 3

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		7 ALA A 506
GLU A 525
MET A 529
VAL A 555
ARG A 616
ALA A 634
ASP A 635
 ACP  A 801 (-3.3A)
ACP  A 801 ( 4.8A)
None
ACP  A 801 (-4.7A)
None
None
MG  A 802 ( 3.0A)
 1.23A 4qrcA-4k33A:
29.6		 4qrcA-4k33A:
77.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4k33 FIBROBLAST GROWTH
FACTOR RECEPTOR 3

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		7 ALA A 506
GLU A 525
MET A 529
VAL A 555
LEU A 608
ARG A 616
ALA A 634
 ACP  A 801 (-3.3A)
ACP  A 801 ( 4.8A)
None
ACP  A 801 (-4.7A)
None
None
None
 0.75A 4qrcA-4k33A:
29.6		 4qrcA-4k33A:
77.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4lg4 SERINE/THREONINE-PRO
TEIN KINASE 3

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  54
GLU A  70
MET A  74
LEU A 137
ALA A 163
 GOL  A 404 ( 3.1A)
None
None
None
GOL  A 403 ( 3.0A)
 0.99A 4qrcA-4lg4A:
20.1		 4qrcA-4lg4A:
25.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4mvf CALCIUM-DEPENDENT
PROTEIN KINASE 2

(Plasmodium
falciparum) 		PF00069
(Pkinase)
PF13499
(EF-hand_7) 		5 ALA A  99
GLU A 117
MET A 121
LEU A 183
ARG A 191
 STU  A 601 (-3.3A)
None
None
None
None
 0.83A 4qrcA-4mvfA:
15.2		 4qrcA-4mvfA:
20.97
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4o27 SERINE/THREONINE-PRO
TEIN KINASE 24

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA B  51
GLU B  70
LEU B 135
ARG B 143
ALA B 161
 ADP  B 500 (-3.3A)
None
None
None
None
 0.82A 4qrcA-4o27B:
19.9		 4qrcA-4o27B:
27.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oav PROTEIN (RNASE L)

(Homo sapiens) 		PF00069
(Pkinase)
PF06479
(Ribonuc_2-5A)
PF12796
(Ank_2)
PF13857
(Ank_5) 		5 ALA B 390
GLU B 404
VAL B 434
LEU B 475
ALA B 502
 ACP  B 801 (-3.2A)
None
ACP  B 801 (-4.8A)
None
None
 0.99A 4qrcA-4oavB:
17.7		 4qrcA-4oavB:
18.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4opf NRPS/PKS

(Streptomyces
albus) 		PF00109
(ketoacyl-synt)
PF02801
(Ketoacyl-synt_C) 		5 ALA A6338
LEU A6344
ARG A6465
ALA A6455
LEU A6138
 None
 1.16A 4qrcA-4opfA:
undetectable		 4qrcA-4opfA:
23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4pxn UNCHARACTERIZED
PROTEIN

(Zea mays) 		PF00171
(Aldedh) 		5 ALA A 170
VAL A 171
CYH A 169
ALA A 164
LEU A 268
 None
None
None
NAD  A 601 (-3.3A)
None
 1.17A 4qrcA-4pxnA:
undetectable		 4qrcA-4pxnA:
25.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4rt7 RECEPTOR-TYPE
TYROSINE-PROTEIN
KINASE FLT3

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 642
GLU A 661
LEU A 802
CYH A 807
ARG A 810
 P30  A1001 (-3.4A)
P30  A1001 (-3.6A)
None
None
None
 1.01A 4qrcA-4rt7A:
28.4		 4qrcA-4rt7A:
40.53
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4tpt LIM DOMAIN KINASE 2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LEU A 442
ARG A 450
ALA A 468
ASP A 469
PHE A 470
 35H  A 701 ( 4.7A)
None
35H  A 701 (-3.5A)
35H  A 701 (-4.7A)
35H  A 701 (-4.4A)
 0.83A 4qrcA-4tptA:
21.7		 4qrcA-4tptA:
29.45
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4ueu TYROSINE KINASE AS -
A COMMON ANCESTOR OF
SRC AND ABL

(synthetic
construct) 		PF07714
(Pkinase_Tyr) 		5 ALA A  35
GLU A  52
MET A  56
LEU A 120
ALA A 146
 ACP  A1264 (-2.9A)
None
None
None
None
 1.02A 4qrcA-4ueuA:
30.9		 4qrcA-4ueuA:
39.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4wsq AP2-ASSOCIATED
PROTEIN KINASE 1

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  72
GLU A  90
MET A  94
LEU A 165
ARG A 175
 KSA  A 405 (-3.2A)
None
None
None
None
 0.82A 4qrcA-4wsqA:
22.9		 4qrcA-4wsqA:
24.38
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xcu FIBROBLAST GROWTH
FACTOR RECEPTOR 4

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		8 ALA A 501
GLU A 520
MET A 524
VAL A 550
CYH A 552
LEU A 603
CYH A 608
ALA A 629
 40M  A1002 ( 4.1A)
40M  A1002 (-3.7A)
40M  A1002 (-3.8A)
40M  A1002 (-4.7A)
40M  A1002 (-1.8A)
None
None
40M  A1002 (-3.0A)
 0.32A 4qrcA-4xcuA:
39.0		 4qrcA-4xcuA:
90.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xcu FIBROBLAST GROWTH
FACTOR RECEPTOR 4

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 ALA A 501
GLU A 520
MET A 524
VAL A 550
LEU A 603
LEU A 633
 40M  A1002 ( 4.1A)
40M  A1002 (-3.7A)
40M  A1002 (-3.8A)
40M  A1002 (-4.7A)
None
None
 1.30A 4qrcA-4xcuA:
39.0		 4qrcA-4xcuA:
90.40
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xuf RECEPTOR-TYPE
TYROSINE-PROTEIN
KINASE FLT3

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 642
GLU A 661
ARG A 810
ASP A 829
PHE A 830
 P30  A1001 (-3.5A)
P30  A1001 (-3.1A)
None
None
P30  A1001 ( 4.1A)
 1.11A 4qrcA-4xufA:
33.7		 4qrcA-4xufA:
47.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
4xuf RECEPTOR-TYPE
TYROSINE-PROTEIN
KINASE FLT3

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 642
GLU A 661
LEU A 802
ARG A 810
PHE A 830
 P30  A1001 (-3.5A)
P30  A1001 (-3.1A)
None
None
P30  A1001 ( 4.1A)
 1.01A 4qrcA-4xufA:
33.7		 4qrcA-4xufA:
47.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5a46 FIBROBLAST GROWTH
FACTOR RECEPTOR 1
(FMS-RELATED
TYROSINE KINASE 2,
PFEIFFER SYNDROME),
ISOFORM CRA_B

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		8 ALA A 512
GLU A 531
MET A 535
VAL A 561
LEU A 614
CYH A 619
ARG A 622
ALA A 640
 38O  A1769 (-3.6A)
EDO  A1766 (-4.1A)
EDO  A1766 (-3.5A)
38O  A1769 (-4.3A)
None
None
None
EDO  A1766 ( 4.4A)
 0.76A 4qrcA-5a46A:
40.3		 4qrcA-5a46A:
64.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5a8f HUMAN SAFFOLD
VIRUS-3 VP2

(Cardiovirus B) 		PF00073
(Rhv) 		5 ALA C  87
VAL C  82
LEU C 198
ALA C 251
LEU C 208
 None
 1.16A 4qrcA-5a8fC:
undetectable		 4qrcA-5a8fC:
22.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ci7 SERINE/THREONINE-PRO
TEIN KINASE ULK1

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  44
GLU A  63
LEU A 129
ARG A 137
ALA A 164
 51W  A 401 (-3.4A)
None
None
TPO  A 180 ( 2.9A)
None
 1.11A 4qrcA-5ci7A:
19.0		 4qrcA-5ci7A:
27.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5e4y HOMOSERINE
O-ACETYLTRANSFERASE

(Pseudomonas
veronii) 		PF00561
(Abhydrolase_1) 		5 ALA A 160
VAL A 136
ALA A  73
ASP A 337
LEU A 333
 None
 0.94A 4qrcA-5e4yA:
undetectable		 4qrcA-5e4yA:
23.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5fm2 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE RECEPTOR RET

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 756
GLU A 775
VAL A 804
LEU A 865
ARG A 873
 PP1  A2012 (-3.2A)
PP1  A2012 (-3.5A)
PP1  A2012 (-4.5A)
None
SEP  A 909 ( 3.0A)
 1.01A 4qrcA-5fm2A:
34.7		 4qrcA-5fm2A:
48.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5grn PLATELET-DERIVED
GROWTH FACTOR
RECEPTOR ALPHA

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 625
GLU A 644
MET A 648
LEU A 809
CYH A 814
 748  A1001 (-3.7A)
748  A1001 (-3.3A)
748  A1001 (-3.4A)
748  A1001 ( 4.6A)
748  A1001 (-3.4A)
 0.46A 4qrcA-5grnA:
26.2		 4qrcA-5grnA:
44.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5hor HEPATOCYTE GROWTH
FACTOR RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A1108
MET A1131
LEU A1195
ARG A1203
ALA A1221
 63K  A1401 (-3.5A)
None
None
None
63K  A1401 (-3.3A)
 1.05A 4qrcA-5horA:
24.7		 4qrcA-5horA:
32.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5idn CYCLIN-DEPENDENT
KINASE 8

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  50
GLU A  66
LEU A 142
ARG A 150
ALA A 172
 6A7  A 401 (-3.3A)
FMT  A 404 ( 4.2A)
None
None
6A7  A 401 ( 4.1A)
 0.95A 4qrcA-5idnA:
15.9		 4qrcA-5idnA:
23.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j5t MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE KINASE KINASE
3

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A  43
GLU A  61
MET A  65
LEU A 127
ALA A 153
 6G2  A 901 (-3.2A)
None
None
None
6G2  A 901 ( 4.2A)
 0.80A 4qrcA-5j5tA:
22.2		 4qrcA-5j5tA:
23.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5j9z EPIDERMAL GROWTH
FACTOR RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 ALA A 743
GLU A 762
MET A 766
LEU A 828
ARG A 836
 6HJ  A1101 (-3.1A)
6HJ  A1101 ( 4.2A)
6HJ  A1101 ( 4.1A)
None
None
 1.04A 4qrcA-5j9zA:
30.8		 4qrcA-5j9zA:
32.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kbr SERINE/THREONINE-PRO
TEIN KINASE PAK 1

(Homo sapiens) 		PF00069
(Pkinase) 		5 ALA A 297
GLU A 315
MET A 319
LEU A 380
ARG A 388
 IPW  A 601 (-3.5A)
IPW  A 601 (-3.9A)
IPW  A 601 (-4.1A)
None
None
 0.88A 4qrcA-5kbrA:
22.3		 4qrcA-5kbrA:
27.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5l7n PLEXIN-A1

(Mus musculus) 		PF01833
(TIG) 		5 ALA A 925
VAL A 903
LEU A 949
ALA A 933
LEU A 867
 None
 1.12A 4qrcA-5l7nA:
undetectable		 4qrcA-5l7nA:
21.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5ul4 OXSB PROTEIN

(Bacillus
megaterium) 		PF02310
(B12-binding) 		5 GLU A 364
CYH A 318
ARG A 317
ALA A 400
ASP A 401
 None
SF4  A 801 (-2.2A)
None
None
None
 1.13A 4qrcA-5ul4A:
undetectable		 4qrcA-5ul4A:
19.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c0t CGMP-DEPENDENT
PROTEIN KINASE 1

(Homo sapiens) 		no annotation 5 ALA A 388
GLU A 409
MET A 413
LEU A 475
ARG A 483
 EE4  A 701 (-3.3A)
DMS  A 702 ( 4.2A)
None
None
TPO  A 517 ( 3.0A)
 1.05A 4qrcA-6c0tA:
16.3		 4qrcA-6c0tA:
14.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6c9d SERINE/THREONINE-PRO
TEIN KINASE
MARK1,SERINE/THREONI
NE-PROTEIN KINASE
MARK1

(Homo sapiens) 		no annotation 5 ALA A  87
GLU A 107
MET A 111
ARG A 181
ALA A 199
 None
 0.75A 4qrcA-6c9dA:
22.4		 4qrcA-6c9dA:
14.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6f5d ATP SYNTHASE ALPHA
CHAIN, MITOCHONDRIAL
ATP SYNTHASE SUBUNIT
BETA

(Trypanosoma
brucei) 		no annotation 5 VAL D 317
LEU D 294
ARG A 222
ALA D 328
LEU D 334
 None
 1.07A 4qrcA-6f5dD:
undetectable		 4qrcA-6f5dD:
17.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6fek PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE RECEPTOR RET

(Homo sapiens) 		no annotation 5 ALA A 756
GLU A 775
VAL A 804
LEU A 865
ARG A 873
 ADN  A1104 (-3.4A)
None
ADN  A1104 ( 4.6A)
None
FMT  A1101 (-2.8A)
 1.05A 4qrcA-6fekA:
34.4		 4qrcA-6fekA:
25.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1b06 PROTEIN (SUPEROXIDE
DISMUTASE)

(Sulfolobus
acidocaldarius) 		PF00081
(Sod_Fe_N)
PF02777
(Sod_Fe_C) 		4 LEU A   6
LYS A  54
ILE A  70
LEU A  74
 None
 0.86A 4qrcA-1b06A:
undetectable		 4qrcA-1b06A:
19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1bh6 SUBTILISIN DY

(Bacillus
licheniformis) 		PF00082
(Peptidase_S8) 		5 LEU A 233
VAL A  84
ILE A 268
ALA A 273
LEU A 250
 None
 1.27A 4qrcA-1bh6A:
undetectable		 4qrcA-1bh6A:
21.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1dhs DEOXYHYPUSINE
SYNTHASE

(Homo sapiens) 		PF01916
(DS) 		5 LEU A 350
VAL A 351
ILE A 112
ALA A 343
LEU A 281
 None
None
None
NAD  A 700 (-3.6A)
None
 1.14A 4qrcA-1dhsA:
undetectable		 4qrcA-1dhsA:
22.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1fc4 2-AMINO-3-KETOBUTYRA
TE CONENZYME A
LIGASE

(Escherichia
coli) 		PF00155
(Aminotran_1_2) 		4 LEU A 394
ILE A 367
ALA A 338
LEU A 332
 None
 0.84A 4qrcA-1fc4A:
undetectable		 4qrcA-1fc4A:
21.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gns SUBTILISIN BPN'

(Bacillus
amyloliquefaciens) 		PF00082
(Peptidase_S8) 		5 LEU A 233
VAL A  84
ILE A 268
ALA A 273
LEU A 250
 None
 1.28A 4qrcA-1gnsA:
undetectable		 4qrcA-1gnsA:
22.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gom ENDO-1,4-BETA-XYLANA
SE

(Thermoascus
aurantiacus) 		PF00331
(Glyco_hydro_10) 		4 VAL A 258
ILE A 204
ALA A 228
ARG A 124
 None
 0.81A 4qrcA-1gomA:
undetectable		 4qrcA-1gomA:
22.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1gzk RAC-BETA
SERINE/THREONINE
PROTEIN KINASE

(Homo sapiens) 		PF00069
(Pkinase)
PF00433
(Pkinase_C) 		4 LEU A 158
VAL A 166
LYS A 181
ALA A 232
 None
 0.85A 4qrcA-1gzkA:
22.2		 4qrcA-1gzkA:
25.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1h1y D-RIBULOSE-5-PHOSPHA
TE 3-EPIMERASE

(Oryza sativa) 		PF00834
(Ribul_P_3_epim) 		4 VAL A 163
ILE A 197
HIS A  36
LEU A 181
 None
 0.78A 4qrcA-1h1yA:
undetectable		 4qrcA-1h1yA:
20.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1i7o 4-HYDROXYPHENYLACETA
TE DEGRADATION
BIFUNCTIONAL
ISOMERASE/DECARBOXYL
ASE

(Escherichia
coli) 		PF01557
(FAA_hydrolase) 		4 VAL A  77
ILE A  86
ALA A 153
LEU A  68
 None
 0.80A 4qrcA-1i7oA:
undetectable		 4qrcA-1i7oA:
23.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1jwa MOLYBDOPTERIN
BIOSYNTHESIS MOEB
PROTEIN

(Escherichia
coli) 		PF00899
(ThiF) 		5 LEU B  58
VAL B  34
ILE B 209
ALA B  53
LEU B  29
 None
 1.44A 4qrcA-1jwaB:
undetectable		 4qrcA-1jwaB:
21.80
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1k2p TYROSINE-PROTEIN
KINASE BTK

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 LEU A 408
VAL A 416
LYS A 430
HIS A 519
LEU A 528
 None
 1.08A 4qrcA-1k2pA:
27.9		 4qrcA-1k2pA:
33.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1krt LYSYL-TRNA
SYNTHETASE (PRODUCT
OF LYSS GENE)

(Escherichia
coli) 		PF01336
(tRNA_anti-codon) 		4 LEU A  97
VAL A  86
ALA A 124
LEU A 143
 None
 0.85A 4qrcA-1krtA:
undetectable		 4qrcA-1krtA:
19.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1luf MUSCLE-SPECIFIC
TYROSINE KINASE
RECEPTOR MUSK

(Rattus
norvegicus) 		PF07714
(Pkinase_Tyr) 		4 VAL A 588
LYS A 608
HIS A 722
LEU A 731
 None
 0.72A 4qrcA-1lufA:
34.2		 4qrcA-1lufA:
40.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1n4d VITAMIN B12
TRANSPORT PROTEIN
BTUF

(Escherichia
coli) 		PF01497
(Peripla_BP_2) 		4 VAL A 160
LYS A 125
ILE A 230
ALA A 232
 None
 0.77A 4qrcA-1n4dA:
undetectable		 4qrcA-1n4dA:
22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1nxk MAP KINASE-ACTIVATED
PROTEIN KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		4 LEU A  70
VAL A  78
LYS A  93
LEU A 193
 STU  A 401 (-3.9A)
STU  A 401 (-4.7A)
STU  A 401 ( 4.5A)
STU  A 401 (-4.7A)
 0.61A 4qrcA-1nxkA:
19.7		 4qrcA-1nxkA:
25.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1obb ALPHA-GLUCOSIDASE

(Thermotoga
maritima) 		PF02056
(Glyco_hydro_4)
PF11975
(Glyco_hydro_4C) 		4 LEU A  20
ILE A  48
ALA A  11
LEU A  37
 None
 0.79A 4qrcA-1obbA:
undetectable		 4qrcA-1obbA:
22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1opk PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1

(Mus musculus) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		5 LEU A 267
VAL A 275
LYS A 290
HIS A 380
LEU A 389
 P16  A   2 ( 4.2A)
P16  A   2 (-4.5A)
P16  A   2 (-4.5A)
None
P16  A   2 (-4.4A)
 0.48A 4qrcA-1opkA:
30.7		 4qrcA-1opkA:
29.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1prx HORF6

(Homo sapiens) 		PF00578
(AhpC-TSA)
PF10417
(1-cysPrx_C) 		4 LEU A 161
ALA A  58
HIS A  39
ARG A 132
 None
None
CSO  A  47 ( 3.9A)
CSO  A  47 ( 4.7A)
 0.84A 4qrcA-1prxA:
undetectable		 4qrcA-1prxA:
20.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1q8y SR PROTEIN KINASE

(Saccharomyces
cerevisiae) 		PF00069
(Pkinase) 		4 LEU A 164
VAL A 172
HIS A 292
LEU A 301
 ADP  A 810 ( 4.3A)
ADP  A 810 (-4.1A)
None
ADP  A 810 (-4.7A)
 0.64A 4qrcA-1q8yA:
21.4		 4qrcA-1q8yA:
24.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1qwj CYTIDINE
MONOPHOSPHO-N-ACETYL
NEURAMINIC ACID
SYNTHETASE

(Mus musculus) 		PF02348
(CTP_transf_3) 		4 VAL A 155
ILE A 140
ALA A  76
LEU A 147
 None
 0.70A 4qrcA-1qwjA:
undetectable		 4qrcA-1qwjA:
19.17
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1rjb FL CYTOKINE RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		4 LEU A 616
VAL A 624
HIS A 809
LEU A 818
 None
 0.37A 4qrcA-1rjbA:
33.7		 4qrcA-1rjbA:
43.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rt8 FIMBRIN

(Schizosaccharomyces
pombe) 		PF00307
(CH) 		5 LEU A 467
VAL A 457
ALA A 485
LEU A 482
ARG A 446
 None
 1.49A 4qrcA-1rt8A:
undetectable		 4qrcA-1rt8A:
19.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1s9i DUAL SPECIFICITY
MITOGEN-ACTIVATED
PROTEIN KINASE
KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		4 LEU A  78
VAL A  86
HIS A 192
LEU A 201
 ATP  A 535 (-3.9A)
ATP  A 535 (-4.1A)
None
ATP  A 535 (-4.8A)
 0.61A 4qrcA-1s9iA:
16.5		 4qrcA-1s9iA:
26.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1scj SUBTILISIN E

(Bacillus
subtilis) 		PF00082
(Peptidase_S8) 		5 LEU A 233
VAL A  84
ILE A 268
ALA A 273
LEU A 250
 None
 1.32A 4qrcA-1scjA:
undetectable		 4qrcA-1scjA:
19.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1smk MALATE
DEHYDROGENASE,
GLYOXYSOMAL

(Citrullus
lanatus) 		PF00056
(Ldh_1_N)
PF02866
(Ldh_1_C) 		4 LEU A 205
VAL A 204
ILE A 243
LEU A 229
 None
 0.85A 4qrcA-1smkA:
undetectable		 4qrcA-1smkA:
23.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1snx TYROSINE-PROTEIN
KINASE ITK/TSK

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		4 VAL A 377
LYS A 391
HIS A 480
LEU A 489
 None
 0.83A 4qrcA-1snxA:
29.7		 4qrcA-1snxA:
31.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1sny SNIFFER CG10964-PA

(Drosophila
melanogaster) 		PF00106
(adh_short) 		4 LEU A  16
VAL A  19
ILE A  57
ALA A  42
 None
 0.71A 4qrcA-1snyA:
undetectable		 4qrcA-1snyA:
23.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1t46 HOMO SAPIENS V-KIT
HARDY-ZUCKERMAN 4
FELINE SARCOMA VIRAL
ONCOGENE HOMOLOG

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		4 LEU A 595
VAL A 603
HIS A 790
LEU A 799
 STI  A   3 ( 3.8A)
STI  A   3 ( 4.6A)
STI  A   3 (-4.5A)
STI  A   3 (-4.4A)
 0.25A 4qrcA-1t46A:
35.2		 4qrcA-1t46A:
48.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1te2 2-DEOXYGLUCOSE-6-P
PHOSPHATASE

(Escherichia
coli) 		PF13419
(HAD_2) 		5 LEU A 161
VAL A 163
ILE A   7
ALA A  10
LEU A 109
 None
 1.18A 4qrcA-1te2A:
undetectable		 4qrcA-1te2A:
23.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1tqx D-RIBULOSE-5-PHOSPHA
TE 3-EPIMERASE,
PUTATIVE

(Plasmodium
falciparum) 		PF00834
(Ribul_P_3_epim) 		4 VAL A 164
ILE A 198
HIS A  36
LEU A 182
 None
None
ZN  A 900 (-3.4A)
None
 0.85A 4qrcA-1tqxA:
undetectable		 4qrcA-1tqxA:
20.99
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
1u59 TYROSINE-PROTEIN
KINASE ZAP-70

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 LEU A 344
VAL A 352
LYS A 369
ALA A 417
HIS A 459
LEU A 468
 STU  A 100 (-3.8A)
STU  A 100 (-4.8A)
STU  A 100 ( 4.7A)
STU  A 100 (-3.7A)
None
STU  A 100 (-4.5A)
 0.59A 4qrcA-1u59A:
30.6		 4qrcA-1u59A:
35.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1u5q SERINE/THREONINE
PROTEIN KINASE TAO2

(Rattus
norvegicus) 		PF00069
(Pkinase) 		5 VAL A  42
LYS A  57
ILE A  89
HIS A 149
LEU A 158
 None
 0.59A 4qrcA-1u5qA:
24.5		 4qrcA-1u5qA:
28.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1ul1 FLAP ENDONUCLEASE-1

(Homo sapiens) 		PF00752
(XPG_N)
PF00867
(XPG_I) 		5 LEU X 263
ILE X 250
ALA X 246
HIS X 280
LEU X 229
 None
 1.30A 4qrcA-1ul1X:
undetectable		 4qrcA-1ul1X:
23.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1un9 DIHYDROXYACETONE
KINASE

(Citrobacter
freundii) 		PF02733
(Dak1)
PF02734
(Dak2) 		4 LEU A 244
VAL A 241
ILE A 285
LEU A 254
 None
 0.72A 4qrcA-1un9A:
undetectable		 4qrcA-1un9A:
21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v0b CELL DIVISION
CONTROL PROTEIN 2
HOMOLOG

(Plasmodium
falciparum) 		PF00069
(Pkinase) 		4 VAL A  18
LYS A  32
HIS A 123
LEU A 132
 None
 0.74A 4qrcA-1v0bA:
22.0		 4qrcA-1v0bA:
25.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v31 HYPOTHETICAL PROTEIN
RAFL11-05-P19

(Arabidopsis
thaliana) 		PF02201
(SWIB) 		5 LEU A  60
VAL A  63
ILE A  32
ALA A  35
LEU A  22
 None
 1.32A 4qrcA-1v31A:
undetectable		 4qrcA-1v31A:
15.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1v8d HYPOTHETICAL PROTEIN
(TT1679)

(Thermus
thermophilus) 		PF04260
(DUF436) 		4 LEU A 119
VAL A 160
ALA A 167
LEU A  65
 None
 0.86A 4qrcA-1v8dA:
undetectable		 4qrcA-1v8dA:
21.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1wer P120GAP

(Homo sapiens) 		PF00616
(RasGAP) 		5 LEU A 930
VAL A 933
ILE A 905
ALA A 908
LEU A 814
 None
 1.44A 4qrcA-1werA:
undetectable		 4qrcA-1werA:
22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1yul PROBABLE
NICOTINATE-NUCLEOTID
E
ADENYLYLTRANSFERASE

(Pseudomonas
aeruginosa) 		PF01467
(CTP_transf_like) 		4 LEU A 105
VAL A 130
ALA A  27
LEU A  32
 None
 0.76A 4qrcA-1yulA:
undetectable		 4qrcA-1yulA:
25.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zlt SERINE/THREONINE-PRO
TEIN KINASE CHK1

(Homo sapiens) 		PF00069
(Pkinase) 		4 LEU A  15
VAL A  23
HIS A 128
LEU A 137
 HYM  A 400 (-4.2A)
HYM  A 400 (-4.3A)
None
HYM  A 400 (-4.5A)
 0.53A 4qrcA-1zltA:
21.8		 4qrcA-1zltA:
27.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zy4 SERINE/THREONINE-PRO
TEIN KINASE GCN2

(Saccharomyces
cerevisiae) 		PF00069
(Pkinase) 		4 LEU A 605
VAL A 613
LYS A 628
HIS A 833
 None
 0.82A 4qrcA-1zy4A:
21.4		 4qrcA-1zy4A:
25.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2aaz THYMIDYLATE SYNTHASE

(Cryptococcus
neoformans) 		PF00303
(Thymidylat_synt) 		4 LEU A 280
VAL A 302
ALA A 232
HIS A  18
 None
 0.83A 4qrcA-2aazA:
undetectable		 4qrcA-2aazA:
23.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ac5 MAP
KINASE-INTERACTING
SERINE/THREONINE
KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		4 VAL A  98
LYS A 113
HIS A 203
LEU A 212
 None
 0.71A 4qrcA-2ac5A:
19.5		 4qrcA-2ac5A:
24.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2bdw HYPOTHETICAL PROTEIN
K11E8.1D

(Caenorhabditis
elegans) 		PF00069
(Pkinase) 		4 VAL A 152
ILE A 116
ALA A 112
LEU A 206
 None
 0.81A 4qrcA-2bdwA:
7.7		 4qrcA-2bdwA:
22.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2buj SERINE/THREONINE-PRO
TEIN KINASE 16

(Homo sapiens) 		PF00069
(Pkinase) 		4 LEU A  26
VAL A  34
LYS A  49
LEU A 155
 STU  A1301 (-4.2A)
STU  A1301 (-4.8A)
STU  A1301 ( 4.0A)
STU  A1301 ( 4.8A)
 0.86A 4qrcA-2bujA:
23.0		 4qrcA-2bujA:
25.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2buj SERINE/THREONINE-PRO
TEIN KINASE 16

(Homo sapiens) 		PF00069
(Pkinase) 		4 VAL A  34
LYS A  49
HIS A 146
LEU A 155
 STU  A1301 (-4.8A)
STU  A1301 ( 4.0A)
None
STU  A1301 ( 4.8A)
 0.84A 4qrcA-2bujA:
23.0		 4qrcA-2bujA:
25.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2c9a RECEPTOR-TYPE
TYROSINE-PROTEIN
PHOSPHATASE MU

(Homo sapiens) 		PF00047
(ig)
PF00629
(MAM) 		4 LEU A 276
VAL A 194
ALA A 228
LEU A 220
 None
 0.81A 4qrcA-2c9aA:
undetectable		 4qrcA-2c9aA:
22.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cqz 177AA LONG
HYPOTHETICAL PROTEIN

(Pyrococcus
horikoshii) 		PF13023
(HD_3) 		4 LEU A 166
VAL A 169
ILE A  40
LEU A  44
 None
 0.86A 4qrcA-2cqzA:
undetectable		 4qrcA-2cqzA:
19.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2cy8 D-PHENYLGLYCINE
AMINOTRANSFERASE

(Pseudomonas
stutzeri) 		PF00202
(Aminotran_3) 		4 LEU A 290
VAL A 289
ALA A 129
LEU A 264
 None
 0.81A 4qrcA-2cy8A:
undetectable		 4qrcA-2cy8A:
20.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dkj SERINE
HYDROXYMETHYLTRANSFE
RASE

(Thermus
thermophilus) 		PF00464
(SHMT) 		4 LEU A  28
VAL A 339
ALA A 378
LEU A 297
 None
 0.83A 4qrcA-2dkjA:
undetectable		 4qrcA-2dkjA:
23.92
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dlc TYROSYL-TRNA
SYNTHETASE,
CYTOPLASMIC

(Saccharomyces
cerevisiae) 		PF00579
(tRNA-synt_1b) 		4 LEU X 266
VAL X 269
ALA X 311
LEU X 317
 None
 0.85A 4qrcA-2dlcX:
undetectable		 4qrcA-2dlcX:
21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dn4 GENERAL
TRANSCRIPTION FACTOR
II-I

(Homo sapiens) 		PF02946
(GTF2I) 		4 LEU A  15
VAL A  12
ILE A  53
LEU A  49
 None
 0.79A 4qrcA-2dn4A:
undetectable		 4qrcA-2dn4A:
15.48
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2dq7 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE FYN

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		4 LEU X  17
VAL X  25
HIS X 128
LEU X 137
 STU  X 902 (-3.8A)
STU  X 902 ( 4.8A)
None
STU  X 902 (-4.4A)
 0.45A 4qrcA-2dq7X:
31.7		 4qrcA-2dq7X:
34.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2dq7 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE FYN

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		4 LEU X  17
VAL X  25
LYS X  39
LEU X 137
 STU  X 902 (-3.8A)
STU  X 902 ( 4.8A)
STU  X 902 (-3.1A)
STU  X 902 (-4.4A)
 0.70A 4qrcA-2dq7X:
31.7		 4qrcA-2dq7X:
34.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dzq GENERAL
TRANSCRIPTION FACTOR
II-I REPEAT
DOMAIN-CONTAINING
PROTEIN 1

(Homo sapiens) 		PF02946
(GTF2I) 		4 LEU A  15
VAL A  12
ILE A  53
LEU A  49
 None
 0.67A 4qrcA-2dzqA:
undetectable		 4qrcA-2dzqA:
13.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2dzr GENERAL
TRANSCRIPTION FACTOR
II-I REPEAT
DOMAIN-CONTAINING
PROTEIN 1

(Homo sapiens) 		PF02946
(GTF2I) 		4 LEU A  15
VAL A  12
ILE A  53
LEU A  49
 None
 0.79A 4qrcA-2dzrA:
undetectable		 4qrcA-2dzrA:
18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2eu9 DUAL SPECIFICITY
PROTEIN KINASE CLK3

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A 162
VAL A 170
LYS A 186
HIS A 281
LEU A 290
 None
 1.02A 4qrcA-2eu9A:
7.7		 4qrcA-2eu9A:
26.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2f9g MITOGEN-ACTIVATED
PROTEIN KINASE FUS3

(Saccharomyces
cerevisiae) 		PF00069
(Pkinase) 		5 LEU A  19
VAL A  27
ILE A  72
HIS A 135
LEU A 144
 ADP  A 500 (-4.3A)
ADP  A 500 (-4.3A)
None
None
ADP  A 500 (-4.3A)
 0.58A 4qrcA-2f9gA:
22.3		 4qrcA-2f9gA:
25.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2g5g PUTATIVE LIPOPROTEIN

(Campylobacter
jejuni) 		PF04187
(Cofac_haem_bdg) 		4 LEU X  44
VAL X 243
ILE X  33
LEU X  64
 None
 0.63A 4qrcA-2g5gX:
undetectable		 4qrcA-2g5gX:
21.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gcd SERINE/THREONINE-PRO
TEIN KINASE TAO2

(Rattus
norvegicus) 		PF00069
(Pkinase) 		5 VAL A  42
LYS A  57
ILE A  89
HIS A 149
LEU A 158
 STU  A 400 ( 4.8A)
STU  A 400 ( 4.5A)
STU  A 400 ( 4.5A)
None
STU  A 400 ( 4.6A)
 0.43A 4qrcA-2gcdA:
25.4		 4qrcA-2gcdA:
28.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gwr DNA-BINDING RESPONSE
REGULATOR MTRA

(Mycobacterium
tuberculosis) 		PF00072
(Response_reg)
PF00486
(Trans_reg_C) 		5 LEU A  71
VAL A  67
ILE A  35
ALA A  44
LEU A   9
 None
 1.27A 4qrcA-2gwrA:
undetectable		 4qrcA-2gwrA:
23.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2h8h PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC

(Homo sapiens) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		4 LEU A 273
VAL A 281
HIS A 384
LEU A 393
 H8H  A 534 (-3.8A)
H8H  A 534 (-4.4A)
None
H8H  A 534 (-4.5A)
 0.49A 4qrcA-2h8hA:
30.1		 4qrcA-2h8hA:
25.09
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hck HEMATOPOETIC CELL
KINASE HCK

(Homo sapiens) 		PF00017
(SH2)
PF00018
(SH3_1)
PF07714
(Pkinase_Tyr) 		4 LEU A 273
VAL A 281
HIS A 384
LEU A 393
 QUE  A   1 (-3.9A)
QUE  A   1 ( 4.8A)
None
QUE  A   1 (-4.4A)
 0.61A 4qrcA-2hckA:
29.6		 4qrcA-2hckA:
30.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2huo INOSITOL OXYGENASE

(Mus musculus) 		PF05153
(MIOX) 		4 LEU A 267
VAL A 264
ALA A 103
LEU A 121
 None
 0.82A 4qrcA-2huoA:
undetectable		 4qrcA-2huoA:
24.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hw6 MAP
KINASE-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 1

(Homo sapiens) 		PF00069
(Pkinase) 		4 LEU A  55
VAL A  63
HIS A 168
LEU A 177
 None
 0.39A 4qrcA-2hw6A:
13.1		 4qrcA-2hw6A:
22.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2hw6 MAP
KINASE-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 1

(Homo sapiens) 		PF00069
(Pkinase) 		4 LEU A  55
VAL A  63
LYS A  78
LEU A 177
 None
 0.54A 4qrcA-2hw6A:
13.1		 4qrcA-2hw6A:
22.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2hz0 PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		4 LEU A 248
VAL A 256
HIS A 361
LEU A 370
 GIN  A 600 ( 4.6A)
GIN  A 600 ( 4.7A)
GIN  A 600 (-4.3A)
GIN  A 600 (-4.7A)
 0.58A 4qrcA-2hz0A:
31.7		 4qrcA-2hz0A:
40.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2icu HYPOTHETICAL PROTEIN
YEDK

(Escherichia
coli) 		PF02586
(SRAP) 		4 ILE A 138
ALA A  83
LEU A 153
ARG A 145
 None
 0.72A 4qrcA-2icuA:
undetectable		 4qrcA-2icuA:
21.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iwi SERINE/THREONINE-PRO
TEIN KINASE PIM-2

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A  38
VAL A  46
ALA A 122
HIS A 161
LEU A 170
 HB1  A1289 ( 4.1A)
HB1  A1289 (-3.6A)
HB1  A1289 ( 4.4A)
None
HB1  A1289 (-4.7A)
 1.19A 4qrcA-2iwiA:
22.0		 4qrcA-2iwiA:
28.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2iwi SERINE/THREONINE-PRO
TEIN KINASE PIM-2

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A  38
VAL A  46
ILE A 100
HIS A 161
LEU A 170
 HB1  A1289 ( 4.1A)
HB1  A1289 (-3.6A)
HB1  A1289 (-4.1A)
None
HB1  A1289 (-4.7A)
 0.70A 4qrcA-2iwiA:
22.0		 4qrcA-2iwiA:
28.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2j0j FOCAL ADHESION
KINASE 1

(Gallus gallus) 		PF00373
(FERM_M)
PF07714
(Pkinase_Tyr) 		4 VAL A 436
LYS A 454
HIS A 544
LEU A 553
 4ST  A1687 ( 4.8A)
4ST  A1687 (-3.4A)
None
4ST  A1687 (-4.4A)
 0.52A 4qrcA-2j0jA:
33.1		 4qrcA-2j0jA:
22.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2jam CALCIUM/CALMODULIN-D
EPENDENT PROTEIN
KINASE TYPE 1G

(Homo sapiens) 		PF00069
(Pkinase) 		4 LEU A  29
VAL A  37
LYS A  52
LEU A 151
 J60  A1305 (-3.9A)
J60  A1305 (-4.8A)
EDO  A1304 ( 2.9A)
None
 0.82A 4qrcA-2jamA:
19.4		 4qrcA-2jamA:
23.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2m1h TRANSCRIPTION
ELONGATION FACTOR
S-II

(Trypanosoma
brucei) 		PF00855
(PWWP) 		4 VAL A  65
ILE A  72
ALA A  25
LEU A  15
 None
 0.83A 4qrcA-2m1hA:
undetectable		 4qrcA-2m1hA:
16.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2nad NAD-DEPENDENT
FORMATE
DEHYDROGENASE

(Pseudomonas sp.
101) 		PF00389
(2-Hacid_dh)
PF02826
(2-Hacid_dh_C) 		4 LEU A 233
VAL A 229
ALA A 205
HIS A 379
 None
None
None
NAD  A 394 ( 4.9A)
 0.85A 4qrcA-2nadA:
undetectable		 4qrcA-2nadA:
22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2nn6 POLYMYOSITIS/SCLEROD
ERMA AUTOANTIGEN 1

(Homo sapiens) 		PF01138
(RNase_PH)
PF03725
(RNase_PH_C) 		4 LYS A 257
ILE A  35
ALA A 148
LEU A  50
 None
 0.62A 4qrcA-2nn6A:
undetectable		 4qrcA-2nn6A:
24.82
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2ogv MACROPHAGE
COLONY-STIMULATING
FACTOR 1 RECEPTOR
PRECURSOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		4 LEU A 588
VAL A 596
HIS A 776
LEU A 785
 None
 0.62A 4qrcA-2ogvA:
33.3		 4qrcA-2ogvA:
45.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ozg GCN5-RELATED
N-ACETYLTRANSFERASE

(Trichormus
variabilis) 		PF13527
(Acetyltransf_9)
PF13530
(SCP2_2) 		4 LEU A 327
VAL A 336
ILE A 289
LEU A 351
 None
 0.78A 4qrcA-2ozgA:
undetectable		 4qrcA-2ozgA:
22.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2ozo TYROSINE-PROTEIN
KINASE ZAP-70

(Homo sapiens) 		PF00017
(SH2)
PF07714
(Pkinase_Tyr) 		5 LEU A 344
VAL A 352
ALA A 417
HIS A 459
LEU A 468
 ANP  A 615 (-4.4A)
ANP  A 615 (-4.5A)
ANP  A 615 (-3.9A)
None
ANP  A 615 (-4.7A)
 1.02A 4qrcA-2ozoA:
28.1		 4qrcA-2ozoA:
22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p0o HYPOTHETICAL PROTEIN
DUF871

(Enterococcus
faecalis) 		PF05913
(DUF871) 		4 LEU A  88
VAL A  90
ILE A  67
ALA A  75
 None
 0.85A 4qrcA-2p0oA:
undetectable		 4qrcA-2p0oA:
22.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p3g MAP KINASE-ACTIVATED
PROTEIN KINASE 2

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU X  70
VAL X  78
LYS X  93
HIS X 184
LEU X 193
 F10  X 401 (-3.9A)
None
F10  X 401 (-4.3A)
None
F10  X 401 ( 4.4A)
 1.16A 4qrcA-2p3gX:
12.3		 4qrcA-2p3gX:
26.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2p4i ANGIOPOIETIN-1
RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 VAL A 838
LYS A 855
ALA A 905
HIS A 962
LEU A 971
 MR9  A 301 (-4.6A)
MR9  A 301 ( 4.6A)
MR9  A 301 (-3.6A)
MR9  A 301 (-4.5A)
MR9  A 301 (-4.5A)
 0.82A 4qrcA-2p4iA:
27.9		 4qrcA-2p4iA:
43.15
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2p4i ANGIOPOIETIN-1
RECEPTOR

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		5 VAL A 838
LYS A 855
ILE A 886
HIS A 962
LEU A 971
 MR9  A 301 (-4.6A)
MR9  A 301 ( 4.6A)
MR9  A 301 (-4.0A)
MR9  A 301 (-4.5A)
MR9  A 301 (-4.5A)
 1.11A 4qrcA-2p4iA:
27.9		 4qrcA-2p4iA:
43.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2p9j HYPOTHETICAL PROTEIN
AQ2171

(Aquifex
aeolicus) 		PF08282
(Hydrolase_3) 		4 LEU A  73
VAL A  75
ILE A  16
LEU A  20
 None
 0.78A 4qrcA-2p9jA:
undetectable		 4qrcA-2p9jA:
17.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pge MENC

(Desulfotalea
psychrophila) 		PF13378
(MR_MLE_C) 		4 LEU A 107
VAL A 112
ALA A 128
LEU A  37
 None
 0.75A 4qrcA-2pgeA:
undetectable		 4qrcA-2pgeA:
22.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2phk PHOSPHORYLASE KINASE

(Oryctolagus
cuniculus) 		PF00069
(Pkinase) 		5 LEU A  25
VAL A  33
ILE A  87
HIS A 147
LEU A 156
 ATP  A 381 ( 4.3A)
ATP  A 381 (-4.1A)
None
None
ATP  A 381 ( 4.8A)
 0.70A 4qrcA-2phkA:
22.9		 4qrcA-2phkA:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2phk PHOSPHORYLASE KINASE

(Oryctolagus
cuniculus) 		PF00069
(Pkinase) 		5 LEU A  25
VAL A  33
LYS A  48
ILE A  87
LEU A 156
 ATP  A 381 ( 4.3A)
ATP  A 381 (-4.1A)
ATP  A 381 (-3.2A)
None
ATP  A 381 ( 4.8A)
 0.81A 4qrcA-2phkA:
22.9		 4qrcA-2phkA:
22.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2pmo SER/THR PROTEIN
KINASE

(Plasmodium
falciparum) 		PF00069
(Pkinase) 		4 LEU X  34
LYS X  55
HIS X 170
LEU X 179
 HMD  X 400 ( 4.3A)
HMD  X 400 (-4.2A)
None
HMD  X 400 (-4.7A)
 0.80A 4qrcA-2pmoX:
21.6		 4qrcA-2pmoX:
21.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2psq FIBROBLAST GROWTH
FACTOR RECEPTOR 2

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		6 LEU A 487
VAL A 495
ILE A 548
ALA A 567
HIS A 624
LEU A 633
 None
 0.56A 4qrcA-2psqA:
36.4		 4qrcA-2psqA:
66.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qo3 ERYAII ERYTHROMYCIN
POLYKETIDE SYNTHASE
MODULES 3 AND 4

(Saccharopolyspora
erythraea) 		PF00109
(ketoacyl-synt)
PF00698
(Acyl_transf_1)
PF02801
(Ketoacyl-synt_C)
PF16197
(KAsynt_C_assoc) 		4 LEU A 509
VAL A 505
ALA A 488
LEU A 534
 None
 0.86A 4qrcA-2qo3A:
undetectable		 4qrcA-2qo3A:
17.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2qp4 BILE SALT
SULFOTRANSFERASE

(Homo sapiens) 		PF00685
(Sulfotransfer_1) 		4 LEU A  95
VAL A  37
LYS A 115
ILE A 198
 None
 0.84A 4qrcA-2qp4A:
undetectable		 4qrcA-2qp4A:
19.39
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
2r4b RECEPTOR
TYROSINE-PROTEIN
KINASE ERBB-4

(Homo sapiens) 		PF07714
(Pkinase_Tyr) 		4 LEU A 724
VAL A 732
HIS A 841
LEU A 850
 GW7  A   1 ( 4.2A)
GW7  A   1 ( 4.8A)
None
GW7  A   1 (-4.2A)
 0.43A 4qrcA-2r4bA:
29.8		 4qrcA-2r4bA:
36.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vd5 DMPK PROTEIN

(Homo sapiens) 		PF00069
(Pkinase) 		4 VAL A  85
LYS A 100
HIS A 193
LEU A 202
 BI8  A1417 ( 4.7A)
BI8  A1417 (-4.2A)
None
BI8  A1417 (-4.8A)
 0.63A 4qrcA-2vd5A:
20.7		 4qrcA-2vd5A:
22.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vgi PYRUVATE KINASE
ISOZYMES R/L

(Homo sapiens) 		PF00224
(PK)
PF02887
(PK_C) 		4 LEU A 236
VAL A 185
ILE A 162
LEU A 254
 None
 0.86A 4qrcA-2vgiA:
undetectable		 4qrcA-2vgiA:
21.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vml PHYCOCYANIN ALPHA
CHAIN

(Gloeobacter
violaceus) 		PF00502
(Phycobilisome) 		4 LEU A 142
VAL A 138
ALA A  41
LEU A  97
 None
 0.86A 4qrcA-2vmlA:
undetectable		 4qrcA-2vmlA:
18.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vmx SERINE
HYDROXYMETHYLTRANSFE
RASE

(Geobacillus
stearothermophilus) 		PF00464
(SHMT) 		4 LEU A  28
VAL A 338
ALA A 377
LEU A 296
 None
 0.75A 4qrcA-2vmxA:
undetectable		 4qrcA-2vmxA:
20.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vuw SERINE/THREONINE-PRO
TEIN KINASE HASPIN

(Homo sapiens) 		PF12330
(Haspin_kinase) 		4 VAL A 498
ILE A 557
HIS A 647
LEU A 656
 5ID  A1800 ( 4.5A)
5ID  A1800 ( 4.5A)
None
5ID  A1800 (-4.5A)
 0.58A 4qrcA-2vuwA:
undetectable		 4qrcA-2vuwA:
22.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2vuw SERINE/THREONINE-PRO
TEIN KINASE HASPIN

(Homo sapiens) 		PF12330
(Haspin_kinase) 		4 VAL A 498
LYS A 511
ILE A 557
LEU A 656
 5ID  A1800 ( 4.5A)
IOD  A1799 (-3.2A)
5ID  A1800 ( 4.5A)
5ID  A1800 (-4.5A)
 0.80A 4qrcA-2vuwA:
undetectable		 4qrcA-2vuwA:
22.37
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w4o CALCIUM/CALMODULIN-D
EPENDENT PROTEIN
KINASE TYPE IV

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A  52
VAL A  60
ILE A 102
HIS A 162
LEU A 171
 DKI  A1338 (-3.8A)
DKI  A1338 (-4.2A)
DKI  A1338 ( 4.4A)
None
DKI  A1338 (-4.9A)
 0.86A 4qrcA-2w4oA:
21.3		 4qrcA-2w4oA:
28.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2w4o CALCIUM/CALMODULIN-D
EPENDENT PROTEIN
KINASE TYPE IV

(Homo sapiens) 		PF00069
(Pkinase) 		5 LEU A  52
VAL A  60
LYS A  75
ILE A 102
LEU A 171
 DKI  A1338 (-3.8A)
DKI  A1338 (-4.2A)
None
DKI  A1338 ( 4.4A)
DKI  A1338 (-4.9A)
 0.76A 4qrcA-2w4oA:
21.3		 4qrcA-2w4oA:
28.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2whx SERINE
PROTEASE/NTPASE/HELI
CASE NS3

(Dengue virus) 		PF00949
(Peptidase_S7)
PF07652
(Flavi_DEAD) 		4 LEU A 128
VAL A 126
ALA A  99
HIS A  51
 None
 0.86A 4qrcA-2whxA:
undetectable		 4qrcA-2whxA:
21.86